Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Nonprofit foundations for open-source biomedical technology development

For academic discoveries eschewed by traditional venture capital business models, there is now an alternative path.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type



Prices may be subject to local taxes which are calculated during checkout

Figure 1


  1. Huggett, B. Nat. Biotechnol. 30, 395–400 (2012).

    Article  CAS  Google Scholar 

  2. Frangioni, J.V. Nat. Biotechnol. 26, 503–507 (2008).

    Article  CAS  Google Scholar 

  3. Frangioni, J.V. J. Clin. Oncol. 26, 4012–4021 (2008).

    Article  Google Scholar 

  4. Mieog, J.S. et al. Ann. Surg. Oncol. 18, 2483–2491 (2011).

    Article  Google Scholar 

  5. Troyan, S.L. et al. Ann. Surg. Oncol. 16, 2943–2952 (2009).

    Article  Google Scholar 

  6. Choi, H.S. et al. Angew. Chem. Int. Edn. Engl. 50, 6258–6263 (2011).

    Article  CAS  Google Scholar 

  7. Gioux, S., Choi, H.S. & Frangioni, J.V. Mol. Imaging 9, 237–255 (2010).

    Article  CAS  Google Scholar 

  8. Hutteman, M. et al. Ann. Surg. Oncol. 18, 1006–1014 (2011).

    Article  Google Scholar 

  9. Lee, B.T. et al. Plast. Reconstr. Surg. 126, 1472–1481 (2010).

    Article  CAS  Google Scholar 

  10. van der Vorst, J.R. et al. Int. J. Gynecol. Cancer 21, 1472–1478 (2011).

    Article  Google Scholar 

Download references


I thank P. Ariniello, C. Colecchi, M. Herman, J. Hoppin, L. Keys, S. Levin, A. Lo, S. Madigan, L. Moffitt, F. Monti, J. Murgia, B. Preston, M. Rosenberg, J. Rosenbloom and M. Tweedle for many helpful discussions and L. Gendall for editing.

Author information

Authors and Affiliations


Corresponding author

Correspondence to John V Frangioni.

Ethics declarations

Competing interests

FLARE technology is owned by Beth Israel Deaconess Medical Center, a teaching hospital of Harvard Medical School, Cambridge, Massachusetts, USA. It has been licensed to the FLARE Foundation, a nonprofit organization focused on promoting the dissemination of medical imaging technology for research and clinical use. J. Frangioni is the founder and chairman of the FLARE Foundation. The Beth Israel Deaconess Medical Center will receive royalties for sale of FLARE Technology. J. Frangioni has elected to surrender post-market royalties to which he would otherwise be entitled as inventor and has elected to donate pre-market proceeds to the FLARE Foundation. J. Frangioni has started three for-profit companies, Curadel, Curadel Medical Devices and Curadel In Vivo Diagnostics, which may someday be non-exclusive sublicensees of FLARE technology.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Frangioni, J. Nonprofit foundations for open-source biomedical technology development. Nat Biotechnol 30, 928–932 (2012).

Download citation

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research